Project title: MEDICINAL COATINGS FOR IMPLANTABLE MEDICAL DEVICES

Company name : ELUTEX LTD.

TECHNOLOGICAL FIELD
Drug Eluting Stents, Orthopedic
Implants

KEY WORDS
Stents, Implants,
Eluting, Restenosis, Nanoparticles

PROJECT SUMMARY
ELUTEX LTD. is dedicated to bringing therapeutic combinations to
medical devices in order to improve performance and patient well
being.
ELUTEX's patented and proprietary electrocoating process is
utilized in coating implantable, metallic medical devices. The
company is positioned to capitalize on the growing trend toward
drug/device combination products and seeks to offer biocompatible
and drug-eluting nanocoatings unto metallic medical devices such
as cardiovascular stents and orthopedic implants.

ELUTEX will initially capitalize on the overwhelming acceptance
of Drug Eluting Stents (DES) within the area of interventional
cardiology. Total U.S. DES market is projected to grow from
almost US $2.6 billion in 2004 to nearly US $6 billion in 2008.

ENTREPRENEURS
Dr. Abraham Domb - Ph.D., Founder and Chief
Scientific Officer
Mr. Norman Sandberg - Chief Executive Officer

PROJECT STATUS
The company was established on December 2003.
Prototype development of Taxol coated stents of less then 2
microns coating thickness.
Currently FDA approved stents contain coatings which are 8 to 15
microns thick.

Intellectual Property Protection:
USPTO - Provisional July 2004
Worldwide - PCT December 2001

COOPERATION REQUIRED
Strategic partnership with leading manufacturers of
cardiovascular stents and orthopaedic implants.
----------------------------------------------------------
TEL: 972-54-6699131, EMAIL: Sandberg@elutex.com

Request for more information, about this project.

Note - you have to be registered in this server to request information. If you haven't done so yet, please:
Register in this server and your requests will be forwarded to the developer, who will contact you directly

List of projects that you already requested more information about